← SearchDEVELOPING MORE POTENT, DUAL EXON-SKIPPING OLIGONUCLEOTIDE THERAPEUTICS FOR DUCHENNE MUSCULAR DYSTROPHY.$0FY2024Defense Health AgencyDODPacdna Llc, Natick MAInvestigatorsView source on USAspending →